Join
Live feed
·
INSIDERFilingvia Quantisnow
ANI Pharmaceuticals Inc. logo

HEAD OF RARE DISEASE Mutz Christopher sold $424,617 worth of shares (5,723 units at $74.19) and covered exercise/tax liability with 3,314 shares, decreasing direct ownership by 9% to 94,471 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANIP (ANI Pharmaceuticals Inc.) and more on Quantisnow.